Science & Space ·
Analysis
Study links GLP-1 drugs to rare vision loss that usually lasts
A Rutgers-led study found roughly three to four additional cases of an optic-nerve condition per 10,000 patients treated over 18 months. The finding calls for attention, but it does not establish the risk for people taking the medicines solely for weight loss.
Read the story · 6 min